His company recently acquired the rights to Daraprim. Developed in the 1950s, the drug is the best treatment for a relatively rare parasitic infection called toxoplasmosis. People with weakened immune systems, such as Aids patients, have come to rely on the drug, which until recently cost about $13.50 (£8.80) a dose.
ncG1vNJzZmivp6x7o67CZ5qopV%2Bjsri%2FjrCmq6SUYsK0ecKapZqckWKAdX%2BSam5vaQ%3D%3D